OptimizeRx Q3 Revenue Falls 17% to $21.6 Million; Updates 2026 Outlook

OptimizeRx reported third-quarter 2026 revenue of $21.6 million, down 17% year over year, and GAAP net income of $1.2 million. Adjusted EBITDA rose to $6.3 million from $5.1 million a year earlier. The company lowered its 2026 revenue outlook to $87 million to $93 million while maintaining its adju…